Drug Eluting Stents Market Analysis by Type (Polymer Free Coating, Polymer-Based Coating), by Geography (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) to 2025

Global Artificial Insemination Market Analysis by Type (Intravaginal, Intratubal, Intrauterine, Intracervical Insemination); by Geography (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) to 2025

Market Synopsis

A drug-eluting stent (DES) is a peripheral or coronary stent placed into narrowed, diseased peripheral or coronary arteries that release a drug to block cell proliferation. This prevents fibrosis that could otherwise block the stented artery, or restenosis. These stents are usually placed within the peripheral or coronary artery by an interventional cardiologist or interventional radiologist during an angioplasty.

Download Sample PDF Brochure: https://www.globalmarketforecasts.com/inquire-before-buying/94

The drug eluting stents market has been growing fast over the past few years due to rising geriatric population, sedentary lifestyles, unhealthy food habits, and lack of exercise. Furthermore, increasing interest of key players, shift from angioplasty to drug eluting stents for the treatment of atherosclerosis are expected to offer significant growth opportunities during next few years. However, risks such as, disruption of endothelial tissue and thrombosis due to drug-eluting stents is expected to restraint the market growth to a certain extent during the forecast period.

The report provides forecast and analysis of the global drug eluting stents market. It provides market overview of global drug eluting stents market of in terms of revenue (in USD Mn). Furthermore, the report includes drivers, restraints, trends and opportunity of the drug eluting stents market and their impact on each country during the forecast period.

Segmentation

Drug eluting stents market, by drug coating is segmented as polymer free coating, polymer-based coating.
Based on applications market is classified as coronary artery disease and peripheral artery disease.
Geographical Analysis:

The drug eluting stents market based on the product coating and application is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North American market is further segmented into US and Canada. The Europe market is categorized into UK, Germany, and France. The market for drug eluting stents in Asia Pacific is segmented into Japan, China, and India. The Latin American market is categorized as Mexico and Brazil. The Middle East & Africa region is classified as South Africa, Saudi Arabia, and UAE.

North America held the largest share of drug eluting stents market owing due to regulatory guidelines for medical devices and manufacturing in the country and high incidence rate of artery diseases. However Asia Pacific is anticipated to grow at the fastest rate in the coming year due to growing patient awareness related to the commercial availability of the products, increasing healthcare spending, constantly improving healthcare infrastructure, and the government funding.

Ask for the Customization: https://www.globalmarketforecasts.com/inquire-before-buying/94

Key Companies:

Both primary and secondary research has been performed during the study. Secondary sources include Factiva, World Bank, and Hoover’s, company annual reports, investor presentations, and publications. The key players included in the global drug eluting stents market are:

Abbott
amg International
Braun Melsungen AG
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
R. Bard, Inc.
Johnson & Johnson

View Detailed Table of Content Here: https://www.globalmarketforecasts.com/selectedReport/94/Drug-Eluting-Stents-Market-Analysis-and-Forecasts-to-2025

About Us:

Global Market Forecasts is a global business intelligence and consulting firm aimed at assisting our clients to make critical business decisions and achieve exponential growth in their business.

We focus on emerging markets and technologies, and insights on niche markets. Our reports include information on recent trends and innovations. Our pool of more than 500+ off-shelf reports in each industry and customized reports based on the client’s requirement aids our client in making faster business decisions.

Contact Us:
Tathagata Mondal

Vice President – Global Sales & Partner Relations

Global Market Forecasts

Phone: USA: +1-201-564-4683 (ext-335958)

UK: +44-330-606-0991(ext-335958)

Email: sales@globalmarketforecasts.com

Website: www.globalmarketforecasts.com

Follow Us on LinkedIn: https://www.linkedin.com/company/global-market-forecasts/

This release was published on openPR.